<i>Materials and Methods</i>: This retrospective, single-center study included 52 patients diagnosed with EGFR-mutant NSCLC who received TKI therapy at Afyonkarahisar Health Sciences University between January 2011 and September 2023. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.